Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2019-07-08 2019-07-08
Drug Identification Number 02394685 02394685
Brand name SANDOZ LATANOPROST/TIMOLOL SANDOZ LATANOPROST/TIMOLOL
Common or Proper name LATANOPROST TIMOLOL LATANOPROST TIMOLOL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TIMOLOL LATANOPROST TIMOLOL LATANOPROST
Strength(s) 5MG 50MCG 5MG 50MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 2.5ML 2.5ML
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date
Actual discontinuation date 2019-06-20 2019-06-20
Remaining supply date 2019-07-08 2019-07-08
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments